Optimal selection of asymptomatic patients for carotid endarterectomy based on predicted 5-year survival

Jessica B Wallaert1, Jack L Cronenwett, Daniel J Bertges

  • 1VA Outcomes Group, Dartmouth Hitchcock Medical Center, Lebanon, NH 03765, USA. jessica.wallaert@hitchcock.org

Insights

Carotid endarterectomy (CEA) for asymptomatic stenosis offers good 5-year survival for most patients. However, high-risk individuals may not live long enough to benefit from this stroke prevention surgery.

Area of Science:

  • Vascular Surgery
  • Cardiovascular Medicine
  • Neurosurgery

Background:

  • Carotid endarterectomy (CEA) is a surgical procedure to prevent stroke in patients with internal carotid artery (ICA) stenosis.
  • Long-term survival is crucial for patients undergoing CEA, particularly those who are asymptomatic.

Purpose of the Study:

  • To examine factors associated with 5-year survival following CEA in patients with asymptomatic ICA stenosis.
  • To identify risk factors for mortality and develop a predictive risk score for 5-year survival post-CEA.

Main Methods:

  • Analysis of prospectively collected data from 4114 isolated CEAs for asymptomatic stenosis (2003-2011).
  • Survival determined using the Social Security Death Index.
  • Cox proportional hazard models used to identify mortality risk factors and calculate a risk score.

Main Results:

  • Overall 5-year survival after CEA was 82%.
  • Factors associated with worse survival included older age, diabetes, smoking, heart failure, COPD, poor renal function, lack of statin use, and contralateral ICA stenosis.
  • Risk stratification identified low (96%), medium (80%), and high (51%) 5-year survival rates.

Conclusions:

  • The majority of asymptomatic patients selected for CEA achieved 5-year survival, indicating appropriate patient selection in the study region.
  • High-risk patients, especially those with multiple major risk factors, may not survive long enough to benefit from prophylactic CEA.
  • Predicting survival is essential for informed decision-making in high-risk patients considered for CEA.
Abstract